{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T04:06:45Z","timestamp":1750910805602,"version":"3.41.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.soc.2024.10.003","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T12:50:15Z","timestamp":1732884615000},"page":"155-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pathology and Classification of Peritoneal Surface Malignancies"],"prefix":"10.1016","volume":"34","author":[{"given":"Jennifer","family":"Vazzano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwini Kumar","family":"Esnakula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.soc.2024.10.003_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41572-021-00326-6","article-title":"Primary and metastatic peritoneal surface malignancies","volume":"7","author":"Cort\u00e9s-Guiral","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1016\/j.soc.2024.10.003_bib2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00018-017-2663-1","article-title":"The peritoneal \u201csoil\u201d for a cancerous \u201cseed\u201d: a comprehensive review of the pathogenesis of intraperitoneal cancer metastases","volume":"75","author":"Miku\u0142a-Pietrasik","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.soc.2024.10.003_bib3","unstructured":"Longacre T, Kim KR and Malpica A, Tumours of peritoneum, In: Cheung, ANY, WHO Classification of Tumours Editorial Board. Female genital tumours [Internet]. Lyon (France): International Agency for Research on Cancer; 2020. (WHO classification of tumours series, 5th ed.; vol. 4). Available at: https:\/\/tumourclassification.iarc.who.int\/chapters\/34."},{"issue":"3","key":"10.1016\/j.soc.2024.10.003_bib4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/his.12651","article-title":"Assessment of a new system for primary site assignment in high-grade serous carcinoma of the fallopian tube, ovary, and peritoneum","volume":"67","author":"Singh","year":"2015","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.soc.2024.10.003_bib5","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1097\/PGP.0000000000000908","article-title":"Data set for the reporting of ovarian, fallopian tube and primary peritoneal carcinoma: recommendations from the international collaboration on cancer reporting (ICCR)","volume":"41","author":"Gilks","year":"2022","journal-title":"Int J Gynecol Pathol"},{"issue":"9","key":"10.1016\/j.soc.2024.10.003_bib6","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/modpathol.2009.90","article-title":"Adenomatoid tumors of the female and male genital tracts: a clinicopathological and immunohistochemical study of 44 cases","volume":"22","author":"Sangoi","year":"2009","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.soc.2024.10.003_bib7","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00428-011-1054-5","article-title":"Adenomatoid tumors of the female and male genital tract. A comparative clinicopathologic and immunohistochemical analysis of 47 cases emphasizing their site-specific morphologic diversity","volume":"458","author":"Wachter","year":"2011","journal-title":"Virchows Arch"},{"issue":"4","key":"10.1016\/j.soc.2024.10.003_bib8","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/modpathol.2017.153","article-title":"Adenomatoid tumors of the male and female genital tract are defined by TRAF7 mutations that drive aberrant NF-kB pathway activation","volume":"31","author":"Goode","year":"2018","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.soc.2024.10.003_bib9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/PAS.0b013e3182354a79","article-title":"Well-differentiated papillary mesothelioma of the female peritoneum: a clinicopathologic study of 26 cases","volume":"36","author":"Malpica","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.soc.2024.10.003_bib10","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/s41379-022-01082-y","article-title":"Well differentiated papillary mesothelial tumor: a new name and new problems","volume":"35","author":"Churg","year":"2022","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.soc.2024.10.003_bib11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41379-018-0127-2","article-title":"Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42","volume":"32","author":"Stevers","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.soc.2024.10.003_bib12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.anndiagpath.2018.10.012","article-title":"Well-differentiated papillary mesothelioma: a 17-year single institution experience with a series of 75 cases","volume":"38","author":"Sun","year":"2019","journal-title":"Ann Diagn Pathol"},{"issue":"1","key":"10.1016\/j.soc.2024.10.003_bib13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41379-021-00899-3","article-title":"Solid papillary mesothelial tumor","volume":"35","author":"Churg","year":"2022","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.soc.2024.10.003_bib14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/gcc.23118","article-title":"NR4A3 fusions characterize a distinctive peritoneal mesothelial neoplasm of uncertain biological potential with pure adenomatoid\/microcystic morphology","volume":"62","author":"Agaimy","year":"2023","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"10.1016\/j.soc.2024.10.003_bib15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41379-019-0347-0","article-title":"Malignant mesothelioma in\u00a0situ: morphologic features and clinical outcome","volume":"33","author":"Churg","year":"2020","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.soc.2024.10.003_bib16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/PAS.0000000000002033","article-title":"Mesothelioma in\u00a0situ mimicking well-differentiated papillary mesothelial tumor","volume":"47","author":"Galateau-Salle","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.soc.2024.10.003_bib17","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.humpath.2018.05.001","article-title":"BAP1 loss is unusual in well-differentiated papillary mesothelioma and may predict development of malignant mesothelioma","volume":"79","author":"Lee","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.soc.2024.10.003_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2020.09.002","article-title":"Whole exome sequencing reveals BAP1 somatic abnormalities in mesothelioma in\u00a0situ","volume":"149","author":"Dacic","year":"2020","journal-title":"Lung Cancer"},{"issue":"6","key":"10.1016\/j.soc.2024.10.003_bib19","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00428-023-03593-8","article-title":"Peritoneal papillary mesothelioma in\u00a0situ: BAP1 mutation with indolent behavior for 15 years","volume":"483","author":"Vitlarov","year":"2023","journal-title":"Virchows Arch"},{"issue":"3","key":"10.1016\/j.soc.2024.10.003_bib20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PAS.0000000000001418","article-title":"Malignant diffuse mesothelioma in women: a study of 354 cases","volume":"44","author":"Pavlisko","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.soc.2024.10.003_bib21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3322\/caac.21572","article-title":"Mesothelioma: scientific clues for prevention, diagnosis, and therapy","volume":"69","author":"Carbone","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.soc.2024.10.003_bib22","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.2147\/CMAR.S170300","article-title":"Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: patient selection and special considerations","volume":"11","author":"Enomoto","year":"2019","journal-title":"Cancer Manag Res"},{"issue":"9","key":"10.1016\/j.soc.2024.10.003_bib23","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00000478-199609000-00004","article-title":"Malignant mesotheliomas presenting as ovarian masses. A report of nine cases, including two primary ovarian mesotheliomas","volume":"20","author":"Clement","year":"1996","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.soc.2024.10.003_bib24","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1309\/2H0NVRERPP2LJDUA","article-title":"Malignant peritoneal mesothelioma in women: a study of 75 cases with emphasis on their morphologic spectrum and differential diagnosis","volume":"123","author":"Baker","year":"2005","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.soc.2024.10.003_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/modpathol.2015.121","article-title":"The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma","volume":"29","author":"Singhi","year":"2016","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.soc.2024.10.003_bib26","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.5858\/arpa.2023-0213-RA","article-title":"Molecular and immunohistochemical testing in mesothelioma and other mesothelial lesions","volume":"148","author":"Hung","year":"2024","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1016\/j.soc.2024.10.003_bib27","doi-asserted-by":"crossref","first-page":"236","DOI":"10.5858\/arpa.2017-0092-OA","article-title":"Immunohistochemistry in peritoneal mesothelioma: a single-center experience of 244 cases","volume":"142","author":"Tandon","year":"2018","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.soc.2024.10.003_bib28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/his.14783","article-title":"Hypothesis: HEG1 and claudin-4 staining will allow a diagnosis of epithelioid and biphasic mesothelioma versus non-small -cell lung carcinoma with only two stains in most cases","volume":"82","author":"Churg","year":"2023","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.soc.2024.10.003_bib29","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/PAT.0000000000000181","article-title":"Diffuse mesothelioma of the peritoneum: correlation between histological and clinical parameters and survival in 73 patients","volume":"46","author":"Liu","year":"2014","journal-title":"Pathology"},{"issue":"5","key":"10.1016\/j.soc.2024.10.003_bib30","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.3802\/jgo.2020.31.e58","article-title":"Incidence and predictors of peritoneal metastases of gynecological origin: a population-based study in The Netherlands","volume":"31","author":"Burg","year":"2020","journal-title":"J\u00a0Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.soc.2024.10.003_bib31","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/PAS.0000000000000692","article-title":"Classification of extraovarian implants in patients with ovarian serous borderline tumors (tumors of low malignant potential) based on clinical outcome","volume":"40","author":"McKenney","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.soc.2024.10.003_bib32","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/PAT.0b013e328348a6e7","article-title":"Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis","volume":"43","author":"McCluggage","year":"2011","journal-title":"Pathology"},{"issue":"3","key":"10.1016\/j.soc.2024.10.003_bib33","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/PAS.0b013e3181868904","article-title":"Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin?","volume":"33","author":"Roh","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"21","key":"10.1016\/j.soc.2024.10.003_bib34","article-title":"The burden of peritoneal metastases from gastric cancer: a systematic review on the incidence, risk factors and survival","volume":"10","author":"Rijken","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.soc.2024.10.003_bib35","doi-asserted-by":"crossref","first-page":"650098","DOI":"10.3389\/fonc.2021.650098","article-title":"Peritoneal metastases from colorectal cancer: defining and addressing the challenges","volume":"11","author":"Kranenburg","year":"2021","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.soc.2024.10.003_bib36","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/MPA.0b013e31825abf8c","article-title":"Incidence, prognosis, and possible treatment strategies of peritoneal carcinomatosis of pancreatic origin: a population-based study","volume":"42","author":"Thomassen","year":"2013","journal-title":"Pancreas"},{"issue":"10","key":"10.1016\/j.soc.2024.10.003_bib37","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.5858\/arpa.2016-0243-RS","article-title":"SATB2 as an immunohistochemical marker for colorectal adenocarcinoma: a concise review of benefits and pitfalls","volume":"141","author":"Berg","year":"2017","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"10.1016\/j.soc.2024.10.003_bib38","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1309\/WF03-NFCE-7BRH-7C26","article-title":"Immunohistochemical labeling for the Dpc4 gene product is a specific marker for adenocarcinoma in biopsy specimens of the pancreas and bile duct","volume":"116","author":"Tascilar","year":"2001","journal-title":"Am J Clin Pathol"},{"issue":"Suppl 1","key":"10.1016\/j.soc.2024.10.003_bib39","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s13193-022-01592-w","article-title":"Peritoneal metastases from extraperitoneal primary tumors: incidence, treatment, and survival from a nationwide database","volume":"14","author":"Rijken","year":"2023","journal-title":"Indian J Surg Oncol"},{"issue":"1","key":"10.1016\/j.soc.2024.10.003_bib40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","article-title":"A\u00a0consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the peritoneal surface Oncology group international (PSOGI) modified delphi process","volume":"40","author":"Carr","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.soc.2024.10.003_bib41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00000658-199402000-00001","article-title":"Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon","volume":"219","author":"Sugarbaker","year":"1994","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.soc.2024.10.003_bib42","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/PAP.0000000000000178","article-title":"An update on the diagnosis, grading, and staging of appendiceal mucinous neoplasms","volume":"25","author":"Valasek","year":"2018","journal-title":"Adv Anat Pathol"},{"issue":"11","key":"10.1016\/j.soc.2024.10.003_bib43","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/modpathol.2014.37","article-title":"Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade","volume":"27","author":"Davison","year":"2014","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1016\/j.soc.2024.10.003_bib44","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1177\/000313481307901120","article-title":"Proposed classification of pseudomyxoma peritonei: influence of signet ring cells on survival","volume":"79","author":"Shetty","year":"2013","journal-title":"Am Surg"},{"key":"10.1016\/j.soc.2024.10.003_bib45","series-title":"AJCC Cancer Staging Manual","first-page":"237","article-title":"Appendix\u2014carcinoma","author":"Overman","year":"2017"},{"key":"10.1016\/j.soc.2024.10.003_bib46","unstructured":"Misdraji J, Carr N, Pai R, et al, Pseudomyxoma peritonei, In: Kim KY, WHO Classification of Tumours Editorial Board. Female genital tumours [Internet]. Lyon (France): International Agency for Research on Cancer; 2020. (WHO classification of tumours series, 5th ed.; vol. 4). Available at: https:\/\/tumourclassification.iarc.who.int\/chapters\/34."},{"issue":"6","key":"10.1016\/j.soc.2024.10.003_bib47","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1245\/s10434-020-08316-w","article-title":"The Chicago Consensus on peritoneal surface malignancies: management of appendiceal neoplasms","volume":"27","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.soc.2024.10.003_bib48","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.5858\/arpa.2021-0430-OA","article-title":"High-grade appendiceal mucinous neoplasm: clinicopathologic findings in 35 cases","volume":"146","author":"Gonzalez","year":"2022","journal-title":"Arch Pathol Lab Med"},{"issue":"12","key":"10.1016\/j.soc.2024.10.003_bib49","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1038\/s41379-019-0302-0","article-title":"A\u00a0combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases","volume":"32","author":"Meagher","year":"2019","journal-title":"Mod Pathol"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320724000802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320724000802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T14:46:23Z","timestamp":1750862783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320724000802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1055320724000802"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2024.10.003","relation":{},"ISSN":["1055-3207"],"issn-type":[{"type":"print","value":"1055-3207"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathology and Classification of Peritoneal Surface Malignancies","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2024.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}